Canada’s IntelGenx has launched a Phase 2a proof-of-concept trial to explore whether the old asthma medication montelukast may be an…
Articles by Magdalena Kegel
Two research teams have independently discovered that a cognition-related gene behaves like a virus in the nervous system — passing on…
Proteins in nerve cell synapses, which transmit signals between neurons, are abnormal in the brains of patients with Alzheimer’s disease…
A group of U.S. researchers hoping to identify already approved medications to repurpose as Alzheimer’s disease treatments has won a…
Another treatment has joined the long list of compounds that have failed to show effectiveness against Alzheimer’s disease. Three Phase…
With 2017 behind us, Alzheimer’s News Today looks forward to bringing our readers news and updates on Alzheimer’s disease…
TauRx Therapeutics’ experimental Alzheimer’s disease treatment LMTX may slow cognitive decline in patients at doses as low as 4…
Anavex Life Sciences has published a study demonstrating the sigma-1 receptor’s role in Alzheimer’s disease. The data contained in…
Billionaire Bill Gates is joining efforts to develop new treatments for Alzheimer’s disease. Gates made the announcement in a…
Anavex Life Sciences says its Alzheimer’s drug candidate Anavex 2-73 may have a role in treating the disease. Data from…